Skip to content
Open access

Mucosal architecture, microbiota resilience and metabolic disruption reveal holobiont dynamics during bovine respiratory disease

Oct 2026 · bioRxiv · 0 citations
Biology

TL;DR

These findings support a holobiont view of BRD in which disease outcomes emerge not only from pathogen-host interactions but also from ecological disturbances that propagate across interconnected mucosal compartments.

Abstract

The gut–airway axis is increasingly recognised as an important determinant of respiratory health in livestock. However, the interactions among respiratory infections, microbial communities, mucosal barrier function, and microbial metabolism that underpin this axis remain poorly understood. Here, we combined longitudinal immunological, mucosal, microbiological, and metabolic analyses to characterise host–microbiota interactions during antibiotic treatment and experimental bovine respiratory disease (BRD). We found that the bovine respiratory tract is organised as a hierarchically structured mucosal ecosystem, with compartment-specific mucin expression patterns associated with distinct microbial communities. Within this framework, increasing respiratory pathogen loads were associated with greater clinical severity, oxidative stress, acute inflammation, and targeted alterations in mucosal regulation and microbial composition, while serum amyloid A emerged as the host biomarker most closely reflecting infection intensity. Although infection altered host and microbial states, antimicrobial treatment represented the dominant ecological perturbation. Antibiotic exposure reshaped both respiratory and intestinal microbial communities, reducing diversity, increasing community drift, and driving coordinated ecological transitions across the gut-airway axis that exceeded the effects of infection alone. Importantly, these compositional changes were accompanied by profound reductions in acetate, propionate, butyrate, and valerate, identifying short-chain fatty acids as a major functional consequence of gut microbiota disruption. Integrative multi-omics analyses revealed that mucosal organisation, microbial diversity, microbial metabolism, and immune activity were embedded within a highly structured gut- airway network. Together, these findings support a holobiont view of BRD in which disease outcomes emerge not only from pathogen-host interactions but also from ecological disturbances that propagate across interconnected mucosal compartments. Notably, antimicrobial treatment affected ecosystem structure and function more than infection itself, highlighting potential trade- offs between pathogen control and microbiota stability. Preserving microbial resilience and its metabolic functions may therefore represent an important component of future strategies to improve respiratory health and disease resilience in cattle.

Read PDF

Similar papers

Review Sep 2026

Heat stress, respiratory dysbiosis, and poultry pathobiome: A comprehensive review of chronic respiratory disease in chickens.

The poultry respiratory microbiome is increasingly recognized as a critical determinant of poultry health, mucosal immunity, and host resistance to opportunistic pathogens. Chronic Respiratory Disease (CRD) exerts a severe economic toll on the global broiler industry. While conventionally attributed to specific etiolog...

Zeinab H. Saleh, M. I. El Enbaawy, M. A. Kamal et al. · 0 citations
Review Open access Sep 2026

The human microbiome and its role in health and disease

The human microbiome encompasses trillions of microorganisms, including bacteria, archaea, fungi, viruses, and protozoa, colonizing virtually every body surface. These communities contribute to digestion, immune regulation, metabolic homeostasis, and protection against pathogens. Disruption of microbial balance, termed...

D. Saini · 0 citations
Review Open access Aug 2026

Mitochondria Meet the Lung Microbiome: A Bidirectional Dialogue in Inflammation and Respiratory Diseases

The respiratory tract is a dynamic biological interface where microbiome, environmental exposure, epithelial integrity, and host metabolic regulation converge to maintain pulmonary homeostasis. Once considered sterile, the lung is now recognized as a low-biomass yet structured microbial ecosystem that contributes to im...

C. Parolin, Emanuele Gentile, C. Pellegrino et al. · 0 citations
Open access Oct 2026

Baseline microbial ecology encodes probiotic responsiveness through distinct metabolic and network configurations.

Probiotic efficacy in inflammatory bowel disease varies widely between individuals, and the sources of that variability remain poorly understood. D-lactate is a microbiota-derived metabolite that accumulates during intestinal inflammation and is associated with epithelial barrier dysfunction, which motivated our use of...

Jia-Qi Li, Ahmet Göktuğ Özkurt, Isabel Baertschi et al. · 0 citations
Review Open access Sep 2026

The gut microbiome–immune axis in inflammatory bowel disease: Microbial mechanisms and therapeutic implications

The human gut microbiome makes up a highly diverse microbial ecosystem that is crucial for host metabolism, immunological modulation, and intestinal barrier integrity. The bacteria phyla Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria dominate the intestinal microbiota, contributing to metabolic processes...

Nooreen Kazi, Nesa Ansari, Aleena Zobairi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.